Previous Close | 203.55 |
Open | 204.76 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 204.76 - 209.46 |
52 Week Range | 195.90 - 242.36 |
Volume | |
Avg. Volume | 1,534 |
Market Cap | 205.443M |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | 0.10 |
EPS (TTM) | 21.78 |
Earnings Date | Apr 25, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Get a deeper insight into the potential performance of Labcorp (LH) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.